Skip to main content

How J&J and AstraZeneca differ from the mRNA vaccines from Pfizer and...

Johnson & Johnson's single-dose COVID-19 vaccine has hit a stumbling block in the United States as regulators begin investigating reports of blood clots, weeks before the first shipment of the jabs are expected to arrive in Canada.
How J&J and AstraZeneca differ from the mRNA vaccines from Pfizer and... image

How J&J and AstraZeneca differ from the mRNA vaccines from Pfizer and Moderna - CP24 Toronto's Breaking News

Johnson & Johnson's single-dose COVID-19 vaccine has hit a stumbling block in the United States as regulators begin investigating reports of blood clots, weeks before the first shipment of the jabs are expected to arrive in Canada.
Read More

In Similar Category

From CP24 Toronto's Breaking News